Results of TRIAS 2009 trial of sorafenib with topotecan in ovarian cancer (video 1:37min) Ovarian Cancer and Us OVARIAN CANCER and US Ovarian Cancer and Us

Blog Archives: Nov 2004 - present

#ovariancancers



Special items: Ovarian Cancer and Us blog best viewed in Firefox

Search This Blog

Tuesday, January 03, 2017

Results of TRIAS 2009 trial of sorafenib with topotecan in ovarian cancer (video 1:37min)



 Blogger's Note: video does not describe AE (side effects)

video
 Posted on : 08/11/16
Description: Jalid Sehouli, MD, PhD from Charité Comprehensive Cancer Center, Berlin, Germany discusses the Phase II TRIAS 2009 trial of sorafenib with topotecan in patients with platinum-resistant recurrent ovarian cancer (NCT01047891). According to Prof. Sehouli, this combination can increase progression-free survival (PFS) and shows an overall survival (OS) benefit compared to the standard treatment.
Recorded at the 2016 Annual Meeting of the American Society of Clinical Oncology (ASCO), held in Chicago, IL. 


0 comments :

Post a Comment

Your comments?